ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Natural Antibodies Are Associated With Rejection And Long-term Renal Allograft Loss In A Multi-center International Cohort

S. B. See1, X. Yang2, C. Burger3, B. Lamarthée4, R. Snanoudj5, R. Shihab1, D. S. Tsapepas6, P. Roy1, S. Larivière-Beaudoin7, K. Hamelin7, A. Mendoza Rojas8, N. M. van Besouw8, A. Bartosic9, N. Daniel9, E. R. Vasilescu10, S. Mohan11, D. Cohen11, L. Ratner11, C. C. Baan8, J. S. Bromberg9, H. Cardinal7, D. Anglicheau3, Y. Sun2, E. Zorn1

1CCTI, Columbia University Irving Medical Center, New York, NY, 2Biostatistics, Columbia University Irving Medical Center, New York, NY, 3Necker Hospital, Paris, France, 4Necker-Enfants Malades Institute, Paris, France, 5Bicêtre Hospital, Paris, France, 6Surgery, Columbia University Irving Medical Center, New York, NY, 7CHUM, Montreal, QC, Canada, 8Erasmus MC, Rotterdam, Netherlands, 9Surgery, University of Maryland School of Medicine, Baltimore, MD, 10Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 11Medicine, Columbia University Irving Medical Center, New York, NY

Meeting: 2022 American Transplant Congress

Abstract number: 1226

Keywords: Antibodies, Graft failure, Kidney transplantation, Rejection

Topic: Basic Science » Basic Science » 04 - B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Potentially harmful non-donor-specific human leukocyte antigen antibodies have been identified in renal transplantation, including natural IgG antibodies (Nabs) reactive to varied antigenic structures.

*Methods: In this retrospective, multi-center study, we assessed Nabs by reactivity to apoptotic cells in sera collected from 1061 kidney transplant recipients across five centers to determine their association with graft outcomes.

*Results: Elevated pre-transplant Nabs were associated with graft loss (hazard ratio (HR) 2.71, 95% confidence interval (CI) 1.15-6.39, P=0.0232), the composite endpoint of graft loss or severe graft dysfunction (HR 2.40, CI 1.13-5.10 P=0.0232) and cellular rejection (odds ratio (OR) 1.77, CI 1.07-3.02, P=0.0310). High pre-transplant Nabs together with donor-specific antibodies (DSA) increased the risk of composite outcomes (HR 6.31, CI 1.81-22.0, P=0.0039). In patients with high pre-transplant Nabs, the subsequent development of post-transplant Nabs was associated with both cellular (OR 3.64, CI 1.61-8.36, p=0.0021) and mixed rejection (OR 3.10, CI 1.02-9.75, p=0.0473). Lastly, elevated pre- and post-transplant Nabs combined with DSA increased the risk of composite outcomes (HR 3.97, CI 1.51-10.43, P=0.0052) and cellular rejection (OR 7.28, CI 2.16 -25.96, P=0.0016).

*Conclusions: The presence of pre- and post-transplant Nabs, together with DSA, contribute to increased risk of poor graft outcomes and rejection following renal transplantation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

See SB, Yang X, Burger C, Lamarthée B, Snanoudj R, Shihab R, Tsapepas DS, Roy P, Larivière-Beaudoin S, Hamelin K, Rojas AMendoza, Besouw NMvan, Bartosic A, Daniel N, Vasilescu ER, Mohan S, Cohen D, Ratner L, Baan CC, Bromberg JS, Cardinal H, Anglicheau D, Sun Y, Zorn E. Natural Antibodies Are Associated With Rejection And Long-term Renal Allograft Loss In A Multi-center International Cohort [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/natural-antibodies-are-associated-with-rejection-and-long-term-renal-allograft-loss-in-a-multi-center-international-cohort/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences